Conclusion
AHF, diabetes
EVENTS, IRON DEFICIENCY, DIABETES
These data suggest that FCM can be used in patients with iron deficiency, with and without diabetes, following an AHF episode to not only reduce clinical events, but also to improve QoL, which is an important outcome from the patient perspective. The high frequency of iron deficiency and diabetes in AHF patients and the associated implications for morbidity and mortality risk highlight the need for both diabetes and iron deficiency screening to enable timely treatment and improved outcomes.